From Endothelial Survival to Lung Protection: Calycosin Attenuates Ischemia–Reperfusion Injury
International Journal of Molecular Sciences · 16.11.2026 · 27 (22) · 10275
DOI: 10.3390/ijms272210275 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.11.2026. Verfasst von Heng Zhao und 8 weiteren Autor:innen. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shaanxi Province Key Research and Development Program.
Abstract (Originalsprache)
Lung ischemia–reperfusion injury (LIRI) contributes to early graft dysfunction after lung transplantation, yet effective pharmacological interventions remain limited. Calycosin (CA), an isoflavone sourced from Astragali Radix, has shown protective effects in experimental ischemic injury, but its effects on LIRI remain insufficiently characterized. We integrated network analysis and molecular docking with experiments in human umbilical vein endothelial cells subjected to oxygen–glucose deprivation/reoxygenation (OGD/R) and male Sprague–Dawley rats undergoing left pulmonary hilar occlusion and reperfusion. Computational analyses highlighted inflammatory signaling, redox regulation, and cell survival, with CA improving endothelial viability and reducing oxidative stress, apoptosis, and inflammatory cytokine levels. In rats, CA reduced histological injury, edema, inflammatory cell accumulation, and lipid peroxidation while improving arterial oxygenation, superoxide dismutase activity, and tissue ATP content. Protection was accompanied by changes in candidate gene expression and PPARγ, COX-2, BAX, and BCL2 protein abundance. In endothelial cells, the PPARγ antagonist GW9662 attenuated the protective effects of CA and its reduction of NF-κB p65 nuclear accumulation. These findings support CA’s potential as a candidate intervention for LIRI and identify PPARγ as a contributor to its endothelial–protective effects, providing a rationale for further evaluation in lung preservation and transplantation models.
Förderung
- National Natural Science Foundation of China
- Shaanxi Province Key Research and Development Program
Zitieren
APA
Zhao, H., Chen, Z., Wang, C., Li, Y., Lin, Y., Wang, H., Li, M., Feng, J., & Zhang, G. (2026). From Endothelial Survival to Lung Protection: Calycosin Attenuates Ischemia–Reperfusion Injury. International Journal of Molecular Sciences, 27(22), 10275. https://doi.org/10.3390/ijms272210275
Vancouver
Zhao H, Chen Z, Wang C, Li Y, Lin Y, Wang H, et al. From Endothelial Survival to Lung Protection: Calycosin Attenuates Ischemia–Reperfusion Injury. International Journal of Molecular Sciences. 2026;27(22):10275. doi:10.3390/ijms272210275
BibTeX
@article{Zhao2026,
author = {Zhao, Heng and Chen, Zhe and Wang, Chi and Li, Yixing and Lin, Yihan and Wang, Hongyi and Li, Ming and Feng, Jinteng and Zhang, Guangjian},
title = {From Endothelial Survival to Lung Protection: Calycosin Attenuates Ischemia–Reperfusion Injury},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {22},
pages = {10275},
doi = {10.3390/ijms272210275}
}
EUVIMED